Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Digestive experts grade treatment options for inflammatory bowel disease

08.04.2011
Causes of IBD explored including 'hygiene hypothesis'

The American College of Gastroenterology published a new evidence-based systematic review on the management of Inflammatory Bowel Disease (IBD) as a supplement to The American Journal of Gastroenterology (AJG) for April 2011, a special issue entirely dedicated to IBD. This clinical monograph, based on a comprehensive meta-analysis, offers new graded recommendations on medical management of IBD, a chronic digestive disorder which includes Crohn's disease (CD) and ulcerative colitis (UC).

A section reviewing the epidemiology of IBD highlights several risk factors, including geography, smoking and appendectomy, the importance of the interplay between genes and environmental factors, including diets high in refined sugar, the role of the gut microbiome and the immune system, as well as the so-called "hygiene hypothesis" as a proposed explanation for the increased incidence of IBD in industrialized nations.

The ACG Institute for Clinical Research & Education convened an expert Task Force to undertake a systematic review of trials evaluating medical therapies of active and quiescent CD and UC. Therapeutic approaches to inducing and maintaining remission, as well as preventing relapse, were included in the analysis. The evidence for the following therapies was included in the systematic review: 5-ASAs, corticosteroids, antibiotics, biologics and immunosuppressants.

"A series of systematic reviews performed by methodologists and supported by IBD experts provides an authoritative perspective on the efficacy of medical therapies in IBD," explained Paul Moayyedi, B.Sc., M.B. Ch.B., Ph.D., MPH, FRCP, FRCPC, FACG, who, along with colleagues at McMaster University and University of Leeds conducted the comprehensive meta-analysis. Dr. Moayyedi also serves as Co-Editor of AJG. "The assessment of all the trials in both UC and CD using the same criteria by one group of researchers gives a unique overview of the strength and quality of the evidence."

"While many review articles, including systematic reviews, have been published on therapy for IBD, the ACG Task Force represents the most rigorous attempt to date to synthesize all of the available evidence in an unbiased fashion. I believe it will prove an invaluable guide for clinicians and investigators," commented Nicholas J. Talley, M.D., Ph.D., FACG, who chaired the ACG IBD Task Force.

"ACG's goal was to highlight the wealth of randomized controlled trial data that can guide the clinician in the medical management of IBD," explained Delbert L. Chumley, M.D, FACG, President of the American College of Gastroenterology.

Highlights of ACG's New Recommendations on IBD Therapies

A summary of the evidence-based recommendations appears in the monograph in a series of Tables, 2 through 5.

Summary of Epidemiological Evidence Offers Fascinating Hypotheses for IBD's Causes

An estimated 1.5 million Americans suffer from UC and CD. Geography is a factor in the incidence of CD. There is a North-South gradient with a strong correlation between degrees latitude and CD incidence when the Western Hemisphere and Western Europe are evaluated. This North-South gradient also exists in the United States, with CD being less common in the South. While a similar epidemiological pattern exists for UC, the North-South gradient is not as pronounced according to the findings presented.

Those with certain immune function predispositions are more like to develop IBD, and the most likely candidate may reside within the gut microbiome, with changes in the gut flora associated with increased risk of IBD in two studies. Dietary factors are also associated with the emergence of IBD, particularly in countries where industrialization has lead to a change in eating patterns and types of foods consumed. One culprit consistently associated with CD is a diet high in refined sugar. Finally, the association with the increased risk of IBD among those living in a cleaner environment, known as the "hygiene hypothesis," points to need to investigate both the immune system and the gut flora as way to enlarge understanding of the causes of IBD, according to the monograph authors.

Online Access

The ACG Evidence-Based Systematic Review on IBS can be accessed online at The American Journal of Gastroenterology Web site. http://www.acg.gi.org/media/releases/ajg201158a.pdf

About IBD

Inflammatory Bowel Disease (IBD) is one of the most common disorders managed by gastroenterologists. Ulcerative colitis and Crohn's disease are two types of IBD. The large intestine (colon) is inflamed in ulcerative colitis, and this involves the inner lining of the colon. In Crohn's disease the inflammation extends deeper into the intestinal wall. Crohn's disease can also involve the small intestine (ileitis), or can involve both the small and large intestine (ileocolitis). IBD develops due to inflammation in the intestine which can result in bleeding, fever, elevation of the white blood cell count, as well as diarrhea and cramping abdominal pain. The abnormalities in IBD can usually be visualized by colonoscopy or cross-sectional imaging (e.g., CT scan.)

Recent advances in basic science research which have revealed new insights into the role of specific immune cells and their mediators in intestinal inflammations. Both UC and CD exhibit a relapsing and remitting course and there is a significant, often dramatic, reduction in patients' quality of life during exacerbations of the disease which has an impact on psychological health.

ACG IBD Expert Task Force

Nicholas J. Talley, M.D., Ph.D., FACG, University of Newcastle, Chair
Maria T. Abreu, M.D., FACG, University of Miami
Jean-Paul Achkar, M.D, FACG, Cleveland Clinic Foundation
Charles N. Bernstein, M.D., FACG, University of Manitoba
Marla C. Dubinsky, UCLA Cedars-Sinai Medical Center
Stephen B. Hanauer, M.D., FACG, University of Chicago
Sunanda V. Kane, M.D., MSPH, FACG, Mayo Clinic, Rochester, MN
William J. Sandborn, M.D., FACG, Mayo Clinic, Rochester, MN
Thomas A. Ullman, M.D., FACG, Mt. Sinai School of Medicine, New York, NY
Paul Moayyedi, B.Sc., MB. Ch.B., Ph.D., MPH, FRCP, FRCPC, FACG, McMaster University

About the American College of Gastroenterology

Founded in 1932, the American College of Gastroenterology is an organization with an international membership of more than 12,000 individuals from 80 countries. The College is committed to serving the clinically oriented digestive disease specialist though its emphasis on scholarly practice, teaching and research. The mission of the College is to serve the evolving needs of physicians in the delivery of high quality, scientifically sound, humanistic, ethical, and cost-effective health care to gastroenterology patients. www.acg.gi.org

The College offers resources for patients and the public on Inflammatory Bowel Disease on the ACG Web site's IBD Resource Page. http://www.acg.gi.org/patients/patientinfo/ibdresources.asp

A series of podcasts with IBD experts addresses common questions and offers pointers on "Living Well with IBD." http://www.acg.gi.org/patients/ibdpodcast.asp

The Official ACG IBD Guidelines can be accessed on the ACG Web site.

Crohn's Disease
(2009)
http://www.acg.gi.org/physicians/guidelines/CrohnsDiseaseinAdults2009.pdf
Ulcerative Colitis
(2010)
http://www.acg.gi.org/physicians/guidelines/UlcerativeColitis.pdf

Jacqueline Gaulin | EurekAlert!
Further information:
http://www.acg.gi.org

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>